A Study of BGM0504 in Participants with Type 2 Diabetes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of BGM0504 in Participants with Type 2 Diabetes — Stella

Home/Type 2 Diabetes Mellitus (T2DM)/

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes Mellitus (T2DM) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Peking University People's Hospital, Beijing, Beijing Municipality

Key details

Phase

Large-scale testing

Sponsor

BrightGene Bio-Medical Technology Co., Ltd.

Collaborators

BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.

Enrollment target

~537 participants

Started

November 2024

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

18 Years – 75 Years

Last updated February 2025